Tecartus Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Brexucabtagene autoleucel, KTE-X19

Filter by location:

Tampa, Florida1 trial

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.